HPR237 Price Determinants and Pricing Policies Concerning Potentially Innovative Health Technologies: A Scoping ReviewN Xander, CA Uyl‐de Groot, Tom Belleman et al.|Value in Health|2024Cited by 0
HPR129 Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal ProductsN Xander, Carin A. Uyl‐de Groot, Maximilian Salcher‐Konrad et al.|Value in Health|2025Cited by 0